Nanoviricides (NNVC) Total Liabilities (2011 - 2026)

Nanoviricides has disclosed Total Liabilities across 16 years of filings, most recently posting $1.1 million for Q1 2026.

• In Q1 2026, Total Liabilities fell 8.25% year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (down 8.25% YoY), while the FY2025 annual figure was $1.3 million, down 4.34% from the prior year.
• Total Liabilities came in at $1.1 million for Q1 2026 at Nanoviricides, down from $1.2 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $2.4 million in Q3 2023 to a low of $348744.0 in Q1 2023.
• Average Total Liabilities over 5 years is $1.1 million, with a median of $1.2 million recorded in 2025.
• Year-over-year, Total Liabilities tumbled 55.62% in 2022 and surged 392.75% in 2023.
• Over 5 years, Total Liabilities stood at $464592.0 in 2022, then jumped by 104.71% to $951074.0 in 2023, then climbed by 26.17% to $1.2 million in 2024, then changed by 0.0% to $1.2 million in 2025, then dropped by 8.33% to $1.1 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $1.1 million in Q1 2026, $1.2 million in Q4 2025, and $1.2 million in Q3 2025.